ATE293638T1 - Synthetische antineoplastische wirkstoffe abgeleitet von dolastatin 15 sowie verfahren zu ihrer herstellung - Google Patents

Synthetische antineoplastische wirkstoffe abgeleitet von dolastatin 15 sowie verfahren zu ihrer herstellung

Info

Publication number
ATE293638T1
ATE293638T1 AT98948504T AT98948504T ATE293638T1 AT E293638 T1 ATE293638 T1 AT E293638T1 AT 98948504 T AT98948504 T AT 98948504T AT 98948504 T AT98948504 T AT 98948504T AT E293638 T1 ATE293638 T1 AT E293638T1
Authority
AT
Austria
Prior art keywords
dolastatin
production
active ingredients
ingredients derived
antineoplastic active
Prior art date
Application number
AT98948504T
Other languages
English (en)
Inventor
George R Pettit
Erik J Flahive
Original Assignee
Univ Arizona
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Arizona filed Critical Univ Arizona
Application granted granted Critical
Publication of ATE293638T1 publication Critical patent/ATE293638T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02Linear peptides containing at least one abnormal peptide link
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K11/00Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT98948504T 1997-09-24 1998-09-23 Synthetische antineoplastische wirkstoffe abgeleitet von dolastatin 15 sowie verfahren zu ihrer herstellung ATE293638T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5985397P 1997-09-24 1997-09-24
PCT/US1998/019954 WO1999015130A2 (en) 1997-09-24 1998-09-23 Synthetic antineoplastic agents derived from dolastatin 15 and methods of making same

Publications (1)

Publication Number Publication Date
ATE293638T1 true ATE293638T1 (de) 2005-05-15

Family

ID=22025701

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98948504T ATE293638T1 (de) 1997-09-24 1998-09-23 Synthetische antineoplastische wirkstoffe abgeleitet von dolastatin 15 sowie verfahren zu ihrer herstellung

Country Status (6)

Country Link
EP (1) EP1049481B1 (de)
JP (1) JP2001517604A (de)
AT (1) ATE293638T1 (de)
CA (1) CA2298639C (de)
DE (1) DE69829881T2 (de)
WO (1) WO1999015130A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016130969A1 (en) 2015-02-13 2016-08-18 George Robert Pettit Silstatin compounds
CN118119409A (zh) 2021-09-03 2024-05-31 东丽株式会社 癌的治疗和/或预防用药物组合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993003054A1 (fr) * 1991-08-09 1993-02-18 Teikoku Hormone Mfg. Co., Ltd. Nouveau derive de tetrapeptide
CA2136339C (en) * 1992-05-20 2008-02-05 Andreas Haupt Derivatives of dolastatin
US5780588A (en) * 1993-01-26 1998-07-14 Arizona Board Of Regents Elucidation and synthesis of selected pentapeptides
US5663149A (en) * 1994-12-13 1997-09-02 Arizona Board Of Regents Acting On Behalf Of Arizona State University Human cancer inhibitory pentapeptide heterocyclic and halophenyl amides
US5807984A (en) * 1995-11-09 1998-09-15 Basf Aktienegesellschaft Oligopeptides, the preparation and use thereof

Also Published As

Publication number Publication date
JP2001517604A (ja) 2001-10-09
EP1049481A4 (de) 2001-09-12
WO1999015130A3 (en) 2000-08-03
DE69829881T2 (de) 2006-03-09
WO1999015130A2 (en) 1999-04-01
CA2298639A1 (en) 1999-04-01
CA2298639C (en) 2005-07-05
DE69829881D1 (de) 2005-05-25
EP1049481B1 (de) 2005-04-20
EP1049481A2 (de) 2000-11-08

Similar Documents

Publication Publication Date Title
DE69933149D1 (de) Substituierte cyclische verbindungen, verfahren zu ihrer herstellung sowie sie enthaltende pharmazeutische zusammensetzungen
DE59108707D1 (de) Verfahren zur Herstellung von Oxetanonen
BG103485A (en) Ketobanzamides as calpain inhibitors
CA2217333A1 (fr) Compositions pour la teinture des fibres keratiniques contenant des diamino pyrazoles, procede de teinture, nouveaux diamino pyrazoles et leur procede de preparation
IE853287L (en) Blockpolyesters, useful as soil release agents in detergent¹compositions
EP1036794A4 (de) 2-aryl-8-oxodihydropurin-derivate, ihre herstellung, ihre verwendung als medikamentenkomponente und deren intermediate
ATE220681T1 (de) Wasserlösliche camptothecin-derivate, verfahren zu deren herstellung und deren verwendung als antitumor-mittel
WO1998035951A3 (en) New aminopiperazine derivatives
ATE156818T1 (de) Polyfluoralkylthiopoly(ethylimidazolium)- verbindungen, verfahren zu ihrer herstellung und ihre verwendung als biozide mittel
DE69515390D1 (de) Ureido-derivate von naphtalenphosphonsäure und verfahren zu ihrer herstellung
DE59407475D1 (de) Lipopeptide aus Actinoplanes sp. mit pharmakologischer Wirkung, Verfahren zu ihrer Herstellung und Verwendung derselben
DE69627166D1 (de) Verfahren zur herstellung von 2-chlor-5-chlomethyl-thiazol-derivaten
EP0749305A4 (de) Verfahren zur herstellung von avermectin/zein-zusammensetzungen
ES2131342T3 (es) Inhibidores de metaloproteinasa.
EA200000431A2 (ru) Новые замещенные димерные соединения, способ их получения и фармацевтические композиции, содержащие их
CA2228945A1 (en) Bactericidal composition
ATE457972T1 (de) Verfahren zur herstellung von 7-amino-syn-3,5- dihydroxyheptansäurederivaten und zwischenverbindungen diesesverfahrens und deren herestellung
WO2001090102A3 (de) 6-heterocyclyl-3-oxo-3,4-dihydro-chinoxaline
NO982229D0 (no) Svovelholdige di-tert-butylfenol-forbindelser anvendbare som antiinflammatoriske midler
ATE293638T1 (de) Synthetische antineoplastische wirkstoffe abgeleitet von dolastatin 15 sowie verfahren zu ihrer herstellung
ATE271043T1 (de) Verfahren zur herstellung von 2-chlor-5- chloromethyl-thiazol
ATE130845T1 (de) Verfahren zur herstellung von 3-amino-2- (het)aroyl-acrylsäurederivaten.
CA2309430A1 (en) Trifluoromethylbiphenylyl-dihalophenylazolines as pesticides
ATE299851T1 (de) Verfahren zur herstellung von zwischenprodukten
DE69610149D1 (de) Verfahren zur Herstellung einer Polyphenolverbindung und positiv-arbeitende, Polyphenolverbindung enthaltende, Fotoresistzusammensetzung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties